<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02154230</url>
  </required_header>
  <id_info>
    <org_study_id>2488/14.06.2012</org_study_id>
    <nct_id>NCT02154230</nct_id>
  </id_info>
  <brief_title>Sulphate-bicarbonate-calcium Water, Body Weight and Gut Microbiota</brief_title>
  <official_title>Effect of Sulphate-bicarbonate-calcium Water Consumption on the Body Weight and Gut Microbiota Composition in Overweight and Obese Patients Under Low-calorie Diet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>TERME DI CHIANCIANO Spa, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Overweight and obese patients will be recruited and randomly assigned to two groups of
      intervention. To the first group [sulphate-bicarbonate-calcium water and low-calorie diet
      (SW-D)] will be administered &quot;Acqua Santa di Chianciano&quot;®, associated to a personalized low
      calorie diet, while the second group [tap water and low-calorie diet (TW-D)] will follow the
      personalized low calorie diet but will be asked to drink the same quantity of tap water, over
      a 4 week period. Stool samples will be collected and analyzed for changes in gut microbiota
      composition. Patients' body weight will be recorded at the beginning and at the end of the
      study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Overweight (BMI&gt;25) and obesity in adults is a global public health concern because weight
      excess increases the relative risk of disease and mortality 1-4. A range of diseases, notably
      cardiovascular disease, diabetes and a number of cancers, are related to excess weight 5.
      Traditional low-calorie diets are frequently ineffective 6. Although a number of
      pharmacological approaches for treatment of obesity have been investigated, only few are safe
      and most of them have adverse effects 7,8. Thus, further studies are necessary in order to
      find natural antiobesity remedies. Gut microbiota composition is thought to influence body
      weight 9.

      As recently demonstrated in our previous study 10, &quot;Acqua Santa di Chianciano&quot;® helps to
      maintain the body weight and the values of serum lipids stable in subjects under a relatively
      high-calorie diet. Possible mechanisms may be a) changing the gut microbiota composition
      and/or b) increasing the concentration and/or the qualitative pattern of serum bile acids
      with a subsequent increase of the energy expenditure 11. This study wants to assess the
      effectiveness in losing weight of &quot;Acqua Santa di Chianciano&quot;® in addition to a low-calorie
      diet and its effects on gut microbiota composition.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>weight loss</measure>
    <time_frame>12 weeks</time_frame>
    <description>The primary end-point of the present study is to assess the effect on body weight of the association between sulphate-bicarbonate-calcium water consumption and low-calorie diet (SW-D) compared to tap water and the low-calorie diet (TW-D). The expected result is to obtain a 50% greater mean weight loss in the SW-D than in the TW-D group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>gut microbiota composition</measure>
    <time_frame>4 weeks</time_frame>
    <description>One of the secondary end-points is the evaluation of the effects of the association between low-calorie diet and sulphate-bicarbonate-calcium water consumption on gut microbiota.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition</measure>
    <time_frame>4 weeks</time_frame>
    <description>One of the secondary end-points is the evaluation of the effects of the association between low-calorie diet and sulphate-bicarbonate-calcium water consumption on body composition (lean body mass/fat body mass) assessed by BIA.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bile acids pool</measure>
    <time_frame>4 weeks</time_frame>
    <description>One of the secondary end-points is the evaluation of the effects of the association between low-calorie diet and sulphate-bicarbonate-calcium water consumption on the bile acids pool.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>energy expenditure</measure>
    <time_frame>4 weeks</time_frame>
    <description>One of the secondary end-points is the evaluation of the effects of the association between low-calorie diet and sulphate-bicarbonate-calcium water consumption on energy expenditure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>thyroid function</measure>
    <time_frame>4 weeks</time_frame>
    <description>One of the secondary end-points is the evaluation of the effects of the association between low-calorie diet and sulphate-bicarbonate-calcium water consumption on thyroid function</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Overweight</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>sulphate-bicarbonate-calcium water and low-calorie diet (SW-D)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental arm: Those patients assigned to this interventional arm of the study will be asked to follow a low-calorie diet. For the first 12 weeks, the diet will cover only basal metabolism expenditure ± 10%. At the end of this 12 weeks, for the following 12 weeks, patients will follow a maintenance diet which will cover both basal metabolism and physical activity expenditure. Patients will be invited to maintain the same level of physical activity preceding enrollment throughout the entire study period. During the first 4 weeks these patients will be asked to drink every morning, before breakfast, within 30 minutes, 500 mL of &quot;Acqua Santa di Chianciano&quot;® at room temperature.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tap water and low-calorie diet (TW-D)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active comparator: Those patients assigned to this interventional arm of the study will be asked to follow the same low-calorie diet of the experimental arm. During the first 4 weeks these patients will be asked to drink every morning, before breakfast, within 30 minutes, 500 mL of Rome tap water at room temperature.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>&quot;Acqua Santa di Chianciano&quot;® (sulphate-bicarbonate-calcium water)</intervention_name>
    <description>During the first 4 weeks the SW-D patients will be asked to drink every morning, before breakfast, within 30 minutes, 500 mL of &quot;Acqua Santa di Chianciano&quot;® at room temperature.</description>
    <arm_group_label>sulphate-bicarbonate-calcium water and low-calorie diet (SW-D)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Tap water</intervention_name>
    <description>During the first 4 weeks the TW-D patients will be asked to drink every morning, before breakfast, within 30 minutes, 500 mL of tap water at room temperature.</description>
    <arm_group_label>tap water and low-calorie diet (TW-D)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with BMI between 29 and 35 kg/m2

          -  Age between 18 and 65 years

        Exclusion Criteria:

          -  Therapy with antibiotics, bile salts, cholestyramine, laxatives, pre- or probiotics
             during the last 3 months before enrollment

          -  Helycobacter Pylori positivity

          -  Previous cholecystectomy

          -  Gallbladder disease

          -  Cholestasis

          -  Consumption of more than 20 g of alcohol/day

          -  Inflammatory bowel diseases

          -  Previous gastrointestinal surgery modifying the anatomy

          -  Pregnancy or lactating state

          -  Prescribed hypocaloric diet in the three previous months
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefano Ginanni Corradini, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Clinical Medicine, Division of Gastroenterology, Sapienza University of Rome, Umberto I Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fredrik Bäckhed, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Wallenberg Laboratory, SU/Sahlgrenska, SE-413 45 Göteborg, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adolfo Francesco Attili</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Medicine, Division of Gastroenterology, Sapienza University of Rome, Umberto I Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alessandro Laviano</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Medicine, Division of Clinical Nutrition, Sapienza University of Rome, Umberto I Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lorenzo Maria Donini</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Experimental Medicine, Division of Medical Physiopathology, Nutrition and Endocrinology, Sapienza University of Rome, Umberto I Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adriano De Santis, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Medicine, Division of Gastroenterology, Sapienza University of Rome, Umberto I Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maurizio Muscaritoli</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Medicine, Division of Clinical Nutrition, Sapienza University of Rome, Umberto I Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isabella Preziosa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Medicine, Division of Clinical Nutrition, Sapienza University of Rome, Umberto I Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefano Ginanni Corradini, MD, PhD</last_name>
    <phone>+39 0649972086</phone>
    <email>stefano.corradini@uniroma1.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fredrik Bäckhed, MD, PhD</last_name>
    <phone>+46 (0)31-342 7833</phone>
    <email>fredrik.backhed@wlab.gu.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Clinical Medicine, Sapienza University of Rome, Umberto I Hospital</name>
      <address>
        <city>Rome</city>
        <zip>00185</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefano Ginanni Corradini, MD, PhD</last_name>
      <phone>+39 0649972086</phone>
      <email>stefano.corradini@uniroma1.it</email>
    </contact>
    <contact_backup>
      <last_name>Fredrik Bäckhed, MD, PhD</last_name>
      <phone>+46 (0)31-342 7833</phone>
      <email>fredrik.backhed@wlab.gu.se</email>
    </contact_backup>
    <investigator>
      <last_name>Stefano Ginanni Corradini, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adolfo Francesco Attili, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alessandro Laviano, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lorenzo Maria Donini, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adriano De Santis, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maurizio Muscaritoli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabella Preziosa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antonio Molinaro, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Canelli Angela, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lucia Parlati, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Flaminia Ferri, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eleonora Poggiogalle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Edoardo Poli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Angela Maffongelli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005 Apr 20;293(15):1861-7.</citation>
    <PMID>15840860</PMID>
  </reference>
  <reference>
    <citation>Gronniger JT. A semiparametric analysis of the relationship of body mass index to mortality. Am J Public Health. 2006 Jan;96(1):173-8. Epub 2005 Aug 30.</citation>
    <PMID>16131644</PMID>
  </reference>
  <reference>
    <citation>Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L; NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003 Jan 7;138(1):24-32.</citation>
    <PMID>12513041</PMID>
  </reference>
  <reference>
    <citation>Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013 Mar;273(3):219-34. doi: 10.1111/joim.12012. Epub 2013 Feb 8. Review.</citation>
    <PMID>23163728</PMID>
  </reference>
  <reference>
    <citation>Jeffery RW, Kelly KM, Rothman AJ, Sherwood NE, Boutelle KN. The weight loss experience: a descriptive analysis. Ann Behav Med. 2004 Apr;27(2):100-6.</citation>
    <PMID>15026294</PMID>
  </reference>
  <reference>
    <citation>Ryan DH, Bray GA, Helmcke F, Sander G, Volaufova J, Greenway F, Subramaniam P, Glancy DL. Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine. Obes Res. 1999 Jul;7(4):313-22.</citation>
    <PMID>10440587</PMID>
  </reference>
  <reference>
    <citation>Carter R, Mouralidarane A, Ray S, Soeda J, Oben J. Recent advancements in drug treatment of obesity. Clin Med (Lond). 2012 Oct;12(5):456-60. Review.</citation>
    <PMID>23101148</PMID>
  </reference>
  <reference>
    <citation>Greiner T, Bäckhed F. Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol Metab. 2011 Apr;22(4):117-23. doi: 10.1016/j.tem.2011.01.002. Epub 2011 Feb 23. Review.</citation>
    <PMID>21353592</PMID>
  </reference>
  <reference>
    <citation>Corradini SG, Ferri F, Mordenti M, Iuliano L, Siciliano M, Burza MA, Sordi B, Caciotti B, Pacini M, Poli E, Santis AD, Roda A, Colliva C, Simoni P, Attili AF. Beneficial effect of sulphate-bicarbonate-calcium water on gallstone risk and weight control. World J Gastroenterol. 2012 Mar 7;18(9):930-7. doi: 10.3748/wjg.v18.i9.930.</citation>
    <PMID>22408352</PMID>
  </reference>
  <reference>
    <citation>Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, Schoonjans K, Bianco AC, Auwerx J. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006 Jan 26;439(7075):484-9. Epub 2006 Jan 8.</citation>
    <PMID>16400329</PMID>
  </reference>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 30, 2014</study_first_submitted>
  <study_first_submitted_qc>May 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2014</study_first_posted>
  <last_update_submitted>June 4, 2014</last_update_submitted>
  <last_update_submitted_qc>June 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>STEFANO GINANNI CORRADINI</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>weight loss</keyword>
  <keyword>sulphate-bicarbonate-calcium water</keyword>
  <keyword>gut microbiota</keyword>
  <keyword>body composition</keyword>
  <keyword>bile salts</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Body Weight</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

